Johnson & Johnson COVID-19 vaccine under review by European Medicines Agency over blood clots – ABC News

Europes drug regulator says it is reviewing rare blood clots in four people in the United States who received Johnson & Johnsons COVID-19 vaccine.
Key points:

• Johnson & Johnson said it was aware of the rare reports of blood clots, and was working with regulators to assess the data
• The US Food and Drug Administration said it was aware of the reports, but they had “not found a causal relationship with vaccination”
• It follows an investigation of blood clots reported by some people given the AstraZeneca…

Click here to view the original article.